VolitionRX (VNRX)

• Market cap: $32M
• 1 day: -3.04%
• 5 days: 15.02%
• 1 month: -11.69%
• 3 months: -24.25%
• 6 months: -64.27%
• Year to date: -13.63%
• 1 year: -59.62%
• 5 years: -94.22%
• 10 years: -93.47%
• Sector: Healthcare
• Industry: Diagnostics & Research

About: VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Employees: 48